{"id":"https://openalex.org/W2011926257","doi":"https://doi.org/10.1124/mi.5.5.8","title":"SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY","display_name":"SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY","alternate_titles":[],"publication_year":2005,"publication_date":"2005-10-01","ids":{"openalex":"https://openalex.org/W2011926257","doi":"https://doi.org/10.1124/mi.5.5.8","mag":"2011926257","pmid":"https://pubmed.ncbi.nlm.nih.gov/16249524"},"language":"en","primary_location":{"id":"doi:10.1124/mi.5.5.8","doi":"https://doi.org/10.1124/mi.5.5.8","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mi.5.5.8","pdf_url":null,"source":{"id":"https://openalex.org/S201362185","display_name":"Molecular Interventions","issn_l":"1534-0384","issn":["1534-0384","1543-2548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Interventions","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011926257"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104024486","display_name":"Keith J. Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"K. J. Miller","raw_affiliation_strings":["Metabolic Diseases Research, HPW 21-2.03, Discovery Biology P.O. Box 5400, Princeton, NJ 08543-5400, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic Diseases Research, HPW 21-2.03, Discovery Biology P.O. Box 5400, Princeton, NJ 08543-5400, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5104024486"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7751,"has_fulltext":false,"cited_by_count":99,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93518519,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"5","issue":"5","first_page":"282","last_page":"291"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.0731000006198883,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.7369999885559082},{"id":"https://openalex.org/keywords/fenfluramine","display_name":"fenfluramine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/dexfenfluramine","display_name":"dexfenfluramine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/norfenfluramine","display_name":"norfenfluramine","score":0.996999979019165},{"id":"https://openalex.org/keywords/weight-loss-agents","display_name":"weight loss agents","score":0.7279999852180481},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.7250000238418579},{"id":"https://openalex.org/keywords/5-ht2b-receptor","display_name":"5-HT2B receptor","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cardiovascular-side-effects","display_name":"cardiovascular side effects","score":0.7739999890327454},{"id":"https://openalex.org/keywords/pulmonary-hypertension","display_name":"pulmonary hypertension","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2779638493","wikidata":"https://www.wikidata.org/wiki/Q418928","display_name":"Fenfluramine","level":4,"score":0.9870900511741638},{"id":"https://openalex.org/C2781083316","wikidata":"https://www.wikidata.org/wiki/Q3025599","display_name":"Dexfenfluramine","level":5,"score":0.9540306329727173},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5959535241127014},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5700069069862366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5697383284568787},{"id":"https://openalex.org/C2777646958","wikidata":"https://www.wikidata.org/wiki/Q424151","display_name":"Sibutramine","level":4,"score":0.48926302790641785},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4796448349952698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4463721513748169},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4217492938041687},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4113103747367859},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40383201837539673},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.38132935762405396},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.3037336468696594}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005277","descriptor_name":"Fenfluramine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005277","descriptor_name":"Fenfluramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009642","descriptor_name":"Norfenfluramine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009642","descriptor_name":"Norfenfluramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D044405","descriptor_name":"Receptor, Serotonin, 5-HT2C","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D044405","descriptor_name":"Receptor, Serotonin, 5-HT2C","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/mi.5.5.8","doi":"https://doi.org/10.1124/mi.5.5.8","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mi.5.5.8","pdf_url":null,"source":{"id":"https://openalex.org/S201362185","display_name":"Molecular Interventions","issn_l":"1534-0384","issn":["1534-0384","1543-2548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Interventions","raw_type":"journal-article"},{"id":"pmid:16249524","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16249524","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular interventions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":83,"referenced_works":["https://openalex.org/W109646337","https://openalex.org/W187576616","https://openalex.org/W1524239110","https://openalex.org/W1554938697","https://openalex.org/W1568479508","https://openalex.org/W1800775388","https://openalex.org/W1927710737","https://openalex.org/W1937517990","https://openalex.org/W1962299285","https://openalex.org/W1964088449","https://openalex.org/W1964255154","https://openalex.org/W1965019847","https://openalex.org/W1968303737","https://openalex.org/W1972470540","https://openalex.org/W1973660081","https://openalex.org/W1977275538","https://openalex.org/W1979278682","https://openalex.org/W1980308824","https://openalex.org/W1980391156","https://openalex.org/W1987570158","https://openalex.org/W1990949140","https://openalex.org/W1991708719","https://openalex.org/W1992197921","https://openalex.org/W1996377543","https://openalex.org/W1997432347","https://openalex.org/W2002212385","https://openalex.org/W2007700773","https://openalex.org/W2008207095","https://openalex.org/W2012346952","https://openalex.org/W2013056388","https://openalex.org/W2014235406","https://openalex.org/W2015127210","https://openalex.org/W2017059860","https://openalex.org/W2019662309","https://openalex.org/W2020482290","https://openalex.org/W2024254226","https://openalex.org/W2028155816","https://openalex.org/W2032787923","https://openalex.org/W2038500073","https://openalex.org/W2039892245","https://openalex.org/W2043774233","https://openalex.org/W2047742792","https://openalex.org/W2049691045","https://openalex.org/W2050191240","https://openalex.org/W2050484443","https://openalex.org/W2053344953","https://openalex.org/W2056420631","https://openalex.org/W2059279128","https://openalex.org/W2059543320","https://openalex.org/W2065982025","https://openalex.org/W2070280529","https://openalex.org/W2071318289","https://openalex.org/W2074562954","https://openalex.org/W2083162388","https://openalex.org/W2083275328","https://openalex.org/W2083974470","https://openalex.org/W2085444790","https://openalex.org/W2085571854","https://openalex.org/W2093562851","https://openalex.org/W2096363966","https://openalex.org/W2097506219","https://openalex.org/W2109141033","https://openalex.org/W2127514796","https://openalex.org/W2134362869","https://openalex.org/W2138765408","https://openalex.org/W2139054225","https://openalex.org/W2139226057","https://openalex.org/W2146966049","https://openalex.org/W2149091344","https://openalex.org/W2153853866","https://openalex.org/W2153950991","https://openalex.org/W2155415459","https://openalex.org/W2157815872","https://openalex.org/W2164339448","https://openalex.org/W2170032365","https://openalex.org/W2172334773","https://openalex.org/W2187182489","https://openalex.org/W2198716551","https://openalex.org/W2202871087","https://openalex.org/W2271897004","https://openalex.org/W2289586083","https://openalex.org/W2406800601","https://openalex.org/W2419155905"],"related_works":["https://openalex.org/W2080778917","https://openalex.org/W4327976003","https://openalex.org/W2039271069","https://openalex.org/W2953127757","https://openalex.org/W4206373691","https://openalex.org/W2056481941","https://openalex.org/W2038644656","https://openalex.org/W2028892248","https://openalex.org/W2262441997","https://openalex.org/W2111337350"],"abstract_inverted_index":{"Obesity":[0],"continues":[1],"to":[2,24,44],"be":[3,25],"a":[4],"burgeoning":[5],"health":[6],"problem":[7],"worldwide.":[8],"Before":[9],"their":[10],"removal":[11],"from":[12],"the":[13,17,27,36,45,53,58,79,95,104],"market,":[14],"fenfluramine":[15,41,101],"and":[16,74,107],"more":[18],"active":[19],"enantiomer":[20],"dexfenfluramine":[21],"were":[22],"considered":[23],"among":[26],"most":[28],"effective":[29],"of":[30,35,48,60,88],"weight":[31,37],"loss":[32,38],"agents.":[33],"Much":[34],"produced":[39],"by":[40],"was":[42],"attributed":[43],"direct":[46],"activation":[47],"serotonin":[49,69],"5-HT(2C)":[50,91],"receptors":[51],"in":[52,84],"central":[54],"nervous":[55],"system":[56],"via":[57],"desmethyl-metabolite":[59],"fenfluramine,":[61],"norfenfluramine.":[62],"Norfenfluramine,":[63],"however,":[64],"is":[65],"non-selective,":[66],"activating":[67],"additional":[68],"receptors,":[70],"such":[71],"as":[72],"5-HT(2A)":[73],"5-HT(2B),":[75],"which":[76],"likely":[77],"mediated":[78],"heart":[80],"valve":[81],"hypertrophy":[82],"seen":[83],"many":[85],"patients.":[86],"Development":[87],"highly":[89],"selective":[90],"agonists":[92],"may":[93],"recapitulate":[94],"clinical":[96],"anti-obesity":[97],"properties":[98],"observed":[99],"with":[100],"while":[102],"avoiding":[103],"significant":[105],"cardiovascular":[106],"pulmonary":[108],"side":[109],"effects.":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011926257","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
